Inflammatory breast cancer (IBC) is a highly aggressive breast cancer that metastasizes largely via tumor emboli. and has a 5-year survival rate of less than 30%. No unique genomic signature has yet been identified for IBC nor has any specific molecular therapeutic been developed to manage the disease. Thus. https://mabelandfoxs.shop/product-category/balaclava/